Cyril Šálek

1.1k total citations
47 papers, 728 citations indexed

About

Cyril Šálek is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Cyril Šálek has authored 47 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 19 papers in Public Health, Environmental and Occupational Health and 14 papers in Molecular Biology. Recurrent topics in Cyril Šálek's work include Acute Myeloid Leukemia Research (26 papers), Acute Lymphoblastic Leukemia research (19 papers) and Chronic Myeloid Leukemia Treatments (13 papers). Cyril Šálek is often cited by papers focused on Acute Myeloid Leukemia Research (26 papers), Acute Lymphoblastic Leukemia research (19 papers) and Chronic Myeloid Leukemia Treatments (13 papers). Cyril Šálek collaborates with scholars based in Czechia, France and United States. Cyril Šálek's co-authors include Jitka Fučíková, Lorenzo Galluzzi, Radek Špíšek, Oliver Kepp, Irena Moserová, Guido Kroemer, Isabelle Cremer, Lenka Kašíková, Iva Truxová and Michal Hensler and has published in prestigious journals such as Blood, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Cyril Šálek

44 papers receiving 722 citations

Peers

Cyril Šálek
Sarah Parisi Italy
Emma F. Barry Australia
Wade Anderson United States
Maria Askmyr Sweden
Bruno A. Cardoso Portugal
Piotr Grabarczyk Germany
Yixiao Gong United States
Anand Jillella United States
Jessica McLeod Canada
Lars Klemm United States
Sarah Parisi Italy
Cyril Šálek
Citations per year, relative to Cyril Šálek Cyril Šálek (= 1×) peers Sarah Parisi

Countries citing papers authored by Cyril Šálek

Since Specialization
Citations

This map shows the geographic impact of Cyril Šálek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyril Šálek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyril Šálek more than expected).

Fields of papers citing papers by Cyril Šálek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyril Šálek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyril Šálek. The network helps show where Cyril Šálek may publish in the future.

Co-authorship network of co-authors of Cyril Šálek

This figure shows the co-authorship network connecting the top 25 collaborators of Cyril Šálek. A scholar is included among the top collaborators of Cyril Šálek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyril Šálek. Cyril Šálek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Svatoň, Michael, Petr Sedláček, Renata Formánková, et al.. (2025). NGS‐MRD negativity in post‐HSCT ALL spares unnecessary therapeutic interventions triggered by borderline qPCR results without an increase in relapse risk. HemaSphere. 9(4). e70124–e70124. 1 indexed citations
2.
Truxová, Iva, Jana Raková, Cyril Šálek, et al.. (2023). Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients. Cell Death and Disease. 14(3). 209–209. 15 indexed citations
3.
Stibůrková, Blanka, Kateřina Pavelcová, Monika Beličková, et al.. (2023). Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome. Arthritis & Rheumatology. 75(7). 1285–1290. 33 indexed citations
4.
Šálek, Cyril, et al.. (2023). ABC transporters are predictors of treatment failure in acute myeloid leukaemia. Biomedicine & Pharmacotherapy. 170. 115930–115930. 7 indexed citations
5.
Kuželová, Kateřina, Barbora Brodská, Jana Marková, et al.. (2022). NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia. OncoImmunology. 11(1). 2073050–2073050. 7 indexed citations
6.
Otáhal, Pavel, et al.. (2022). Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies. Frontiers in Oncology. 12. 876758–876758. 14 indexed citations
7.
8.
Burda, Pavel, Tomáš Kalina, Veronika Kanderová, et al.. (2021). Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining. Frontiers in Oncology. 11. 744373–744373. 7 indexed citations
9.
10.
Válková, Veronika, Jan Vydra, Iuri Marinov, et al.. (2020). WT1 Gene Expression in Peripheral Blood Before and After Allogeneic Stem Cell Transplantation is a Clinically Relevant Prognostic Marker in AML – A Single-center 14-year Experience. Clinical Lymphoma Myeloma & Leukemia. 21(2). e145–e151. 5 indexed citations
11.
12.
Brodská, Barbora, et al.. (2019). High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant NPM1 and FLT3 Mutations. International Journal of Molecular Sciences. 20(11). 2823–2823. 41 indexed citations
13.
Vydra, Jan, Veronika Válková, Michal Kolář, et al.. (2019). Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Aplasia After Cladribine/Cytarabine Chemotherapy for Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome. Clinical Lymphoma Myeloma & Leukemia. 19(6). 365–371. 1 indexed citations
14.
Šálek, Cyril, et al.. (2019). DNA Methylation Validation Methods: a Coherent Review with Practical Comparison. Biological Procedures Online. 21(1). 19–19. 77 indexed citations
15.
Truxová, Iva, Lenka Kašíková, Cyril Šálek, et al.. (2019). Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients. Haematologica. 105(7). 1868–1878. 43 indexed citations
16.
Březinová, Jana, Zuzana Zemanová, Adéla Berková, et al.. (2018). High frequency of dicentric chromosomes detected by multi-centromeric FISH in patients with acute myeloid leukemia and complex karyotype. Leukemia Research. 68. 85–89. 2 indexed citations
17.
Vydra, Jan, Cyril Šálek, Jiřı́ Schwarz, et al.. (2017). Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission. Clinical Lymphoma Myeloma & Leukemia. 18(2). 106–113. 2 indexed citations
18.
Burda, Pavel, et al.. (2016). GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia. PLoS ONE. 11(3). e0152234–e0152234. 18 indexed citations
19.
Marková, Jana, et al.. (2011). Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression. Experimental and Therapeutic Medicine. 3(1). 129–133. 10 indexed citations
20.
Šálek, Cyril, Jan Trka, Jan Vydra, et al.. (2010). [Treatment of adult acute lymphoblastic leukemia according to GMALL 07/2003 study protocol in the Czech Republic - the first experience].. PubMed. 56(3). 176–82. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Parisi Breakdown of academic impact, for papers by Emma F. Barry Breakdown of academic impact, for papers by Wade Anderson Breakdown of academic impact, for papers by Maria Askmyr Breakdown of academic impact, for papers by Bruno A. Cardoso Breakdown of academic impact, for papers by Piotr Grabarczyk Breakdown of academic impact, for papers by Yixiao Gong Breakdown of academic impact, for papers by Anand Jillella Breakdown of academic impact, for papers by Jessica McLeod Breakdown of academic impact, for papers by Lars Klemm
Rankless by CCL
2026